U.S. states sue Mylan, Teva, others for fixing drug prices

Two years after high generic drug prices became a public controversy, legal cases are starting to land. Twenty states filed a lawsuit Thursday against Mylan NV , Teva Pharmaceuticals and four other generic drug makers, saying they conspired over steak dinners and "girls nights out" on pricing of two common generic drugs, according to a copy of the complaint. The civil lawsuit, led by antitrust investigators in Connecticut, comes one day after the U.S. Department of Justice filed criminal charges against two generic drug industry executives, alleging that they colluded to fix prices and split up market share.